These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34527683)

  • 1. Antiviral Therapy for Chronic HBV Infection With Persistently Normal Alanine Aminotransferase: Controversy and Consensus.
    Zhou J; Wang FD; Wang ML; Tao YC; Wu DB; Sheng YJ; Xiao GB; Chen XB; Chen X; Chen EQ
    Front Med (Lausanne); 2021; 8():717125. PubMed ID: 34527683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NIH consensus development statement on management of hepatitis B.
    Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
    NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran.
    Makvandi M; Soleimani Jelodar R; Samarbafzadeh A; Neisi N; Sharifi Z; Gholampour A; Masjedizadeh A; Shayesteh A
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2125-2129. PubMed ID: 30139211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic hepatitis B: case selection and duration of therapy.
    Leung N
    J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk factors associated with the progression of chronic HBV infection in patients with normal ALT].
    Wei L; Li H; Hu P
    Zhonghua Gan Zang Bing Za Zhi; 2020 Dec; 28(12):995-998. PubMed ID: 34865345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of chronic hepatitis B: an update.
    Morgan M; Park W; Keeffe EB
    Minerva Gastroenterol Dietol; 2007 Mar; 53(1):25-41. PubMed ID: 17415343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Optimal timing significance and clinical implications for the treatment of chronic HBV-infected patients with normal ALT].
    Fan YX; Dou XG
    Zhonghua Gan Zang Bing Za Zhi; 2020 Dec; 28(12):985-987. PubMed ID: 34865342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?
    Song BC; Cho YK; Jwa H; Choi EK; Kim HU; Song HJ; Na SY; Boo SJ; Jeong SU
    Clin Mol Hepatol; 2014 Dec; 20(4):355-60. PubMed ID: 25548741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: a prospective cohort study with paired transient elastography examination.
    Wong GL; Chan HL; Yu Z; Chan HY; Tse CH; Wong VW
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1842-8. PubMed ID: 23829381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
    Chu CM
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBV: Do I treat my immunotolerant patients?
    Vlachogiannakos J; Papatheodoridis GV
    Liver Int; 2016 Jan; 36 Suppl 1():93-9. PubMed ID: 26725904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alanine aminotransferase normalization with antiviral therapies in hepatitis B].
    Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2019 Oct; 27(10):741-747. PubMed ID: 31734986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic necroinflammation and severe liver fibrosis in patients with chronic hepatitis B with undetectable HBV DNA and persistently normal alanine aminotransferase.
    Alam MM; Mahtab MA; Akbar SM; Kamal M; Rahman S
    Bangladesh Med Res Counc Bull; 2014 Dec; 40(3):92-6. PubMed ID: 26402972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of chronic hepatitis B: 2009 update.
    Morgan M; Keeffe EB
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):5-22. PubMed ID: 19212304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?
    Papatheodoridis GV; Manesis EK; Manolakopoulos S; Elefsiniotis IS; Goulis J; Giannousis J; Bilalis A; Kafiri G; Tzourmakliotis D; Archimandritis AJ
    Hepatology; 2008 Nov; 48(5):1451-9. PubMed ID: 18924246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approach to the patient with chronic hepatitis B and decompensated cirrhosis.
    Shiffman ML
    Liver Int; 2020 Feb; 40 Suppl 1():22-26. PubMed ID: 32077612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of chronic hepatitis B.
    Park W; Keeffe EB
    Minerva Gastroenterol Dietol; 2004 Dec; 50(4):289-303. PubMed ID: 15788985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleos(t)ide Analogue Treatment for Patients With Hepatitis B Virus (HBV) e Antigen-Positive Chronic HBV Genotype C Infection: A Nationwide, Multicenter, Retrospective Study.
    Chang Y; Choe WH; Sinn DH; Lee JH; Ahn SH; Lee H; Shim JJ; Jun DW; Park SY; Nam JY; Cho EJ; Yu SJ; Lee DH; Lee JM; Kim YJ; Kwon SY; Paik SW; Yoon JH
    J Infect Dis; 2017 Dec; 216(11):1407-1414. PubMed ID: 29029102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection.
    Brahmania M; Lombardero M; Hansen BE; Terrault NA; Lok AS; Perrillo RP; Belle SH; Di Bisceglie AM; Feld JJ; Lee WM; Fried MW; Janssen HLA;
    Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2541-2551.e2. PubMed ID: 30743006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.